HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hahn Young Kim Selected Research

Neuroinflammatory Diseases

11/2017Chronic cerebral hypoperfusion induces post-stroke dementia following acute ischemic stroke in rats.
2/2016Characterization of White Matter Injury in a Rat Model of Chronic Cerebral Hypoperfusion.
9/2011Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model.
9/2006Matrix metalloproteinases in cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hahn Young Kim Research Topics

Disease

19Stroke (Strokes)
11/2021 - 04/2010
9Cognitive Dysfunction
01/2021 - 06/2011
8Ischemic Stroke
01/2020 - 04/2005
4Neuroinflammatory Diseases
11/2017 - 09/2006
4Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
02/2016 - 08/2014
3Reperfusion Injury
09/2014 - 12/2006
3Pathologic Constriction (Stenosis)
05/2014 - 10/2011
3Ischemia
10/2013 - 12/2006
3Neoplasms (Cancer)
03/2013 - 04/2010
2Alzheimer Disease (Alzheimer's Disease)
01/2020 - 12/2014
2Cerebral Hemorrhage
01/2020 - 02/2013
2Hemorrhagic Stroke
01/2020 - 02/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 10/2012
2Brain Injuries (Brain Injury)
02/2013 - 09/2006
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2012 - 12/2006
1Acute Disease
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Critical Illness (Critically Ill)
01/2022
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021
1Insulin Resistance
01/2020
1Transient Global Amnesia
01/2018
1Hyperlipidemias (Hyperlipidemia)
01/2018
1Myalgia
01/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2017
1Constipation
01/2017
1Diabetes Mellitus
01/2015
1Dementia (Dementias)
01/2015
1Epilepsy (Aura)
02/2013
1Neural Tube Defects (Exencephaly)
01/2013
1Autism Spectrum Disorder
01/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2012
1Traumatic Brain Injuries (Traumatic Brain Injury)
10/2012
1Syncope (Fainting)
07/2012
1Heart Arrest (Cardiac Arrest)
07/2012
1Hypoxia (Hypoxemia)
02/2011
1Hypokinesia (Bradykinesia)
09/2010
1Myocardial Infarction
09/2010
1Infarction (Infarctions)
12/2006

Drug/Important Bio-Agent (IBA)

8Cilostazol (Pletal)FDA LinkGeneric
01/2021 - 10/2011
5EscitalopramFDA Link
11/2021 - 01/2017
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 10/2011
2Serotonin (5 Hydroxytryptamine)IBA
11/2021 - 01/2018
2Pharmaceutical PreparationsIBA
01/2021 - 02/2013
2Probucol (Lorelco)FDA Link
01/2021 - 01/2020
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 11/2017
2Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2018 - 09/2013
2DNA (Deoxyribonucleic Acid)IBA
07/2018 - 08/2014
2Superoxides (Superoxide)IBA
08/2014 - 04/2005
2Plasminogen Activator Inhibitor 1IBA
10/2013 - 02/2011
2Valproic Acid (Depakote)FDA LinkGeneric
02/2013 - 01/2013
2fibrin fragment D (D-dimer)IBA
06/2011 - 04/2010
1Biomarkers (Surrogate Marker)IBA
01/2022
1Insulin-Like Growth Factor Binding ProteinsIBA
01/2022
1Tissue Inhibitor of MetalloproteinasesIBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
11/2021
1Dizocilpine Maleate (Dizocilpine)IBA
01/2021
1Streptozocin (Streptozotocin)FDA Link
01/2020
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2019
1MethyltransferasesIBA
07/2018
1DecitabineFDA Link
07/2018
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2018
1Aquaporin 4IBA
11/2017
1Dopamine (Intropin)FDA LinkGeneric
11/2016
1Dopamine Receptors (Dopamine Receptor)IBA
11/2016
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
11/2016
1Dopamine Agents (Dopaminergic Agents)IBA
11/2016
1Proteins (Proteins, Gene)FDA Link
02/2016
1Myelin Basic ProteinIBA
02/2016
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2015
1Phosphodiesterase 3 InhibitorsIBA
01/2015
1Type 3 Cyclic Nucleotide PhosphodiesterasesIBA
01/2015
1Donepezil (Aricept)FDA LinkGeneric
12/2014
1Cholinesterase Inhibitors (Anticholinesterases)IBA
12/2014
1GadoliniumIBA
09/2014
1acetovanillone (apocynin)IBA
08/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2014
1NADPH Oxidase 1IBA
08/2014
1theasinensin AIBA
09/2013
1macelignanIBA
03/2013
1Hemoglobins (Hemoglobin)IBA
02/2013
1Neuroprotective AgentsIBA
02/2013
1Heme Oxygenase-1IBA
02/2013
1Glutamic Acid (Glutamate)FDA Link
10/2012
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2012
15233705 compoundIBA
10/2012
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
10/2012
1Clopidogrel (Plavix)FDA Link
10/2011
1salicylhydroxamic acid (SHAM)IBA
09/2011
1Amyloid beta-PeptidesIBA
09/2011
1AnticoagulantsIBA
06/2011
1Cholinergic Agents (Cholinergics)IBA
06/2011
1TroponinIBA
09/2010
1Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
12/2006

Therapy/Procedure

9Therapeutics
07/2018 - 04/2005
1Drug Therapy (Chemotherapy)
01/2021
1Secondary Prevention
01/2018
1Gastrectomy
07/2012
1Vagotomy
07/2012
1Lasers (Laser)
01/2012